Apostroph Group

About Apostroph Group

Apostroph Group is the market leading platform for demanding translations in the DACH region. The group is focused on project management, quality assurance and handling services for highly complex translation projects, supported by a self-developed technology platform and access to an accredited pool of 2,000 translators. While Apostroph Switzerland (acquisition in 2017) focuses on clients in the pharmaceutical, medical, chemical, industrial, insurance and financial sectors, WIENERS+WIENERS (acquisition in 2016) mainly serves advertising agencies and the PR and marketing departments of companies spanning every sector of the economy. With its medDOC® division, LÓPEZ-EBRI (acquisition in 2018) has successfully positioned itself among the market leaders for translations in the fields of medicine, medical technology, pharmaceuticals, dentistry and dental technology. Also part of the group is BVIW (acquisition in 2019), which is primarily focused on high-quality language services in PR and communications.

Strategy

The Apostroph Group has been created by the implementation of a buy-and-build strategy in the language service market by GEP IV since 2016. In addition to further acquisitions in the DACH market and the integration of the acquisitions, management, with the support of GEP IV, continues to drive organic growth by expanding sales, marketing and the technological platform.

Quick Facts

Name:  Apostroph Group
Sector:  Language service provider
Location:  Ahrensburg, Germany
Investment background:  Buy-and-build
Year of investment:  2016 (first investment)
Funds:  GEP IV
Sales:  ∼ €25m
Employees:  ∼ 120
Website:  apostrophgroup.de
Back to portfolio